Zynex Operating Margin 2010-2024 | ZYXI
Current and historical operating margin for Zynex (ZYXI) over the last 10 years. The current operating profit margin for Zynex as of September 30, 2024 is 2.49%.
| Zynex Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-09-30 | $0.19B | $0.01B | 4.64% |
| 2024-06-30 | $0.19B | $0.01B | 5.15% |
| 2024-03-31 | $0.19B | $0.01B | 5.82% |
| 2023-12-31 | $0.18B | $0.01B | 5.43% |
| 2023-09-30 | $0.19B | $0.02B | 9.68% |
| 2023-06-30 | $0.18B | $0.02B | 11.24% |
| 2023-03-31 | $0.17B | $0.02B | 12.35% |
| 2022-12-31 | $0.16B | $0.02B | 14.47% |
| 2022-09-30 | $0.15B | $0.03B | 16.67% |
| 2022-06-30 | $0.14B | $0.03B | 18.18% |
| 2022-03-31 | $0.14B | $0.03B | 18.98% |
| 2021-12-31 | $0.13B | $0.02B | 17.69% |
| 2021-09-30 | $0.12B | $0.01B | 11.21% |
| 2021-06-30 | $0.10B | $0.01B | 5.94% |
| 2021-03-31 | $0.09B | $0.01B | 6.74% |
| 2020-12-31 | $0.08B | $0.01B | 11.25% |
| 2020-09-30 | $0.07B | $0.01B | 16.18% |
| 2020-06-30 | $0.06B | $0.01B | 20.00% |
| 2020-03-31 | $0.05B | $0.01B | 21.57% |
| 2019-12-31 | $0.05B | $0.01B | 24.44% |
| 2019-09-30 | $0.04B | $0.01B | 25.00% |
| 2019-06-30 | $0.04B | $0.01B | 30.56% |
| 2019-03-31 | $0.03B | $0.01B | 32.35% |
| 2018-12-31 | $0.03B | $0.01B | 34.38% |
| 2018-09-30 | $0.03B | $0.01B | 38.71% |
| 2018-06-30 | $0.03B | $0.01B | 40.00% |
| 2018-03-31 | $0.03B | $0.01B | 40.74% |
| 2017-12-31 | $0.02B | $0.01B | 39.13% |
| 2017-09-30 | $0.02B | $0.01B | 33.33% |
| 2017-06-30 | $0.02B | $0.00B | 26.67% |
| 2017-03-31 | $0.01B | $0.00B | 15.38% |
| 2016-12-31 | $0.01B | $0.00B | 15.38% |
| 2016-09-30 | $0.01B | 0 | 0.00% |
| 2016-06-30 | $0.01B | $-0.00B | -8.33% |
| 2016-03-31 | $0.01B | $-0.00B | -8.33% |
| 2015-12-31 | $0.01B | $-0.00B | -16.67% |
| 2015-09-30 | $0.01B | 0 | 0.00% |
| 2015-06-30 | $0.01B | 0 | 0.00% |
| 2015-03-31 | $0.01B | $-0.01B | -50.00% |
| 2014-12-31 | $0.01B | $-0.01B | -50.00% |
| 2014-09-30 | $0.01B | $-0.01B | -90.91% |
| 2014-06-30 | $0.01B | $-0.01B | -91.67% |
| 2014-03-31 | $0.02B | $-0.01B | -56.25% |
| 2013-12-31 | $0.02B | $-0.01B | -38.10% |
| 2013-09-30 | $0.03B | $-0.00B | -10.34% |
| 2013-06-30 | $0.03B | $-0.00B | -2.94% |
| 2013-03-31 | $0.04B | $0.00B | 7.69% |
| 2012-12-31 | $0.04B | $0.00B | 7.50% |
| 2012-09-30 | $0.04B | $0.00B | 7.69% |
| 2012-06-30 | $0.04B | $0.00B | 7.89% |
| 2012-03-31 | $0.04B | $0.00B | 8.33% |
| 2011-12-31 | $0.03B | $0.00B | 8.82% |
| 2011-09-30 | $0.03B | $0.00B | 9.68% |
| 2011-06-30 | $0.03B | $0.00B | 10.34% |
| 2011-03-31 | $0.03B | $0.00B | 7.41% |
| 2010-12-31 | $0.03B | $0.00B | 8.00% |
| 2010-09-30 | $0.02B | $0.00B | 4.35% |
| 2010-06-30 | $0.02B | $0.00B | 4.76% |
| 2010-03-31 | $0.02B | $0.00B | 10.53% |
| 2009-12-31 | $0.02B | $0.00B | 16.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.268B | $0.184B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $194.987B | 24.87 |
| Stryker (SYK) | United States | $136.147B | 30.68 |
| Boston Scientific (BSX) | United States | $130.670B | 37.57 |
| EssilorLuxottica (ESLOY) | France | $110.026B | 0.00 |
| Medtronic (MDT) | Ireland | $102.570B | 15.24 |
| Haleon (HLN) | United Kingdom | $43.909B | 28.53 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.293B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.376B | 18.35 |
| ResMed (RMD) | United States | $33.995B | 27.93 |
| Terumo (TRUMY) | Japan | $28.800B | 40.67 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 18.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.064B | 13.41 |
| Insulet (PODD) | United States | $17.996B | 71.67 |
| Baxter (BAX) | United States | $14.756B | 9.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.838B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.021B | 40.32 |
| Bio-Rad Laboratories (BIO) | United States | $9.125B | 31.01 |
| Demant (WILYY) | Denmark | $7.926B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.392B | 14.85 |
| Prestige Consumer Healthcare (PBH) | United States | $3.886B | 19.33 |
| Haemonetics (HAE) | United States | $3.862B | 18.85 |
| ICU Medical (ICUI) | United States | $3.751B | 35.71 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.33 |
| Envista Holdings (NVST) | United States | $3.103B | 23.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.894B | 18.63 |
| GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
| Neogen (NEOG) | United States | $2.605B | 30.05 |
| LeMaitre Vascular (LMAT) | United States | $2.074B | 50.41 |
| Green Thumb Industries (GTBIF) | United States | $1.630B | 28.52 |
| AtriCure (ATRC) | United States | $1.465B | 0.00 |
| InMode (INMD) | Israel | $1.444B | 8.68 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.371B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.32 |
| BioLife Solutions (BLFS) | United States | $1.211B | 0.00 |
| Owens & Minor (OMI) | United States | $0.973B | 7.60 |
| CeriBell (CBLL) | United States | $0.958B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.955B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.883B | 15.58 |
| Evolus (EOLS) | United States | $0.688B | 0.00 |
| Omeros (OMER) | United States | $0.593B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 26.15 |
| Capricor Therapeutics (CAPR) | United States | $0.587B | 0.00 |
| Surmodics (SRDX) | United States | $0.572B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.445B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Quanterix (QTRX) | United States | $0.383B | 0.00 |
| ZimVie (ZIMV) | United States | $0.373B | 31.44 |
| Valneva SE (VALN) | France | $0.353B | 0.00 |
| Biote (BTMD) | United States | $0.313B | 6.86 |
| Viemed Healthcare (VMD) | United States | $0.312B | 29.70 |
| Canopy Growth (CGC) | Canada | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.293B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.283B | 18.95 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| High Tide (HITI) | Canada | $0.237B | 98.00 |
| Aurora Cannabis (ACB) | Canada | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.54 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Organigram Holdings (OGI) | Canada | $0.184B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
| Brainsway (BWAY) | Israel | $0.169B | 89.60 |
| FitLife Brands (FTLF) | United States | $0.151B | 19.04 |
| Jin Medical (ZJYL) | China | $0.132B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.110B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.79 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Exagen (XGN) | United States | $0.083B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.17 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.82 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |